中国实用神经疾病杂志
中國實用神經疾病雜誌
중국실용신경질병잡지
CHINESE JOURNAL OF PRACTICAL NERVOUS DISEASES
2014年
21期
8-10
,共3页
储备能力%辛伐他汀%缺血性脑血管
儲備能力%辛伐他汀%缺血性腦血管
저비능력%신벌타정%결혈성뇌혈관
Cerebrovascular reserve capacity%Simvastatin%Ischemic cerebrovascular disease
目的:研究不同剂量辛伐他汀对缺血性脑血管患者脑血管储备能力的影响。方法将90例缺血性脑血管患者分为常规组、强化组和对照组。对照组患者口服拜阿司匹林,对症治疗;常规组患者服用常规剂量辛伐他汀治疗;强化组服用强化剂量辛伐他汀治疗。检测比较患者治疗前后的脑血管储备能力。结果治疗6个月后,常规组屏气指数为1·21±0·13,脑血管储备能力为30·44±5·09;强化组屏气指数为1·54±0·11,脑血管储备能力为36·14±5·13;对照组的屏气指数为0·95±0·11,脑血管储备能力为21·42±5·20。3组患者的屏气指数和脑血管储备能力较治疗前均有一定程度增加,但强化组增加的幅度最明显。结论强化剂量的辛伐他汀对患者CVR有较好疗效。
目的:研究不同劑量辛伐他汀對缺血性腦血管患者腦血管儲備能力的影響。方法將90例缺血性腦血管患者分為常規組、彊化組和對照組。對照組患者口服拜阿司匹林,對癥治療;常規組患者服用常規劑量辛伐他汀治療;彊化組服用彊化劑量辛伐他汀治療。檢測比較患者治療前後的腦血管儲備能力。結果治療6箇月後,常規組屏氣指數為1·21±0·13,腦血管儲備能力為30·44±5·09;彊化組屏氣指數為1·54±0·11,腦血管儲備能力為36·14±5·13;對照組的屏氣指數為0·95±0·11,腦血管儲備能力為21·42±5·20。3組患者的屏氣指數和腦血管儲備能力較治療前均有一定程度增加,但彊化組增加的幅度最明顯。結論彊化劑量的辛伐他汀對患者CVR有較好療效。
목적:연구불동제량신벌타정대결혈성뇌혈관환자뇌혈관저비능력적영향。방법장90례결혈성뇌혈관환자분위상규조、강화조화대조조。대조조환자구복배아사필림,대증치료;상규조환자복용상규제량신벌타정치료;강화조복용강화제량신벌타정치료。검측비교환자치료전후적뇌혈관저비능력。결과치료6개월후,상규조병기지수위1·21±0·13,뇌혈관저비능력위30·44±5·09;강화조병기지수위1·54±0·11,뇌혈관저비능력위36·14±5·13;대조조적병기지수위0·95±0·11,뇌혈관저비능력위21·42±5·20。3조환자적병기지수화뇌혈관저비능력교치료전균유일정정도증가,단강화조증가적폭도최명현。결론강화제량적신벌타정대환자CVR유교호료효。
Objective To investigate the effects of different does simvastatin on the cerebrovascular reserve capacity (CVR) of patients with ischemic cerebrovascular disease·Methods 90 patients with ischemic cerebrovascular disease were di-vided into the control group (treated with oral bayaspirin) ,convention group (treated with conventional does simvastatin ) and strengthened group (treated with strengthened does simvastatin)· The cerebrovascular reserve capacities of three groups were compared·Results After being treated for 6 months ,the breath-holding index and CVR were 1·21 ± 0·13 and 30·44 ± 5·09 in the convention group ,1·54 ± 0·11 and 36·14 ± 5·13 in the strengthened group ,0·95 ± 0·11 and 21·42 ± 5·20 in the control group ,respectively· Compared with pretreatment ,the breath-holding index and CVR of three groups had certain degree of in-crease ,especially in the strengthened group·Conclusion Strengthened does simvastatin has better effect on the CVR of pa-tients w ith ischemic cerebrovascular disease.